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Clinics 
Age and sex 
89 years old female patient. 
Previous history 
no preleukemia  
no previous malignancy  
no inborn condition of note 
Organomegaly 
No hepatomegaly, splenomegaly (moderate), 
enlarged lymph nodes, no central nervous system 
involvement  
Blood 
WBC : 144 (lymphoma cells : 93%) Morphology 
showed small to medium sized lymphoid cells with 
pale cytoplasm and slightly to markedly irregular 
nuclear contour, sometimes mimicking centrocytes. 
Nucleoli were inconspicuous or absent.X 109/l 
HB : 12.8g/dl 
Platelets : 196X 109/l 
Blasts : NA 
Bone marrow : Bone marrow involvement (stage 
IV Ann Arbor). 
Note 
Rapid progression of the disease because 6 months 
ago laboratory analyses were normal (notably blood 
count). 
Cyto-Pathology 
Classification 
Phenotype: NA 
Immunophenotype 
lymphoma cells CD19+ CD5+ CD20+ (strong), 
CD22+ (strong), CD23+, FMC7+, monotypic kappa 
light-chain expression (moderate); Matutes score = 
2/5. 
Rearranged Ig Tcr 
Not performed. 
Pathology 
Mantle cell lymphoma 
Electron microscopy 
Not performed. 
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Diagnosis 
Mature B-cell neoplasm, cyclin D1-negative mantle 
cell lymphoma. 
Survival 
Date of diagnosis: 10-2014 
Treatment 
10/2014: Patient first received chloraminophene and 
rituximab (2 courses). 12/2014: Patient was then 
treated with ibrutinib (140 mg x 4/day). 
Complete remission : no   
Treatment related death : no   
Relapse : no   
Status: Dead 
Last follow up: 01-2015 
Survival: 4 months 
Karyotype 
Sample: Bone marrow 
Culture time: 96h DSP30/IL2 
Banding: GTG 
Results 
45,XX,t(2;12)(p12;p13),add(9)(p13),add(11)(q23),-
22[7]/46,XX[7] 
Other molecular cytogenetics technics 
FISH 
Other molecular cytogenetics results 
45,XX,t(2;12)(p12;p13). ish 
der(2)t(2;12)(WCP12p+), 
der(12)t(2;12)(WCP12p+)[2]. 
 
 
 
 
Other Molecular Studies 
Technics: 
CCND1 (BCL1) expression evaluated by RT-PCR. 
Results: 
No CCND1 overexpression. 
 
Partial GTG-banding karyotype of the t(2;12)(p12;p13). 
 
 
FISH analysis of the t(2;12)(p12;p13)translocation, using 
painting probe of the short arm of chromosome 12 
(WCP12p probe)in green. Arrows indicate the der(2) and 
der(12) chromosomes. 
 
FISH analysis of the t(2;12) translocation, using BAC probe CCND2 RP11-264F23 in red and BAC probe RP11-530J6 located at 
2q33 in green. Figure 3A is a normal metaphase and Figure 3B revealed the der(2) chromosome harboring CCND2 red signal. 
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Leukemic phase of mantle cell lymphoma. Peripheral blood. Small to medium sized lymphoid cells with pale cytoplasm and 
slightly too markedly irregular nuclear contour, sometimes mimicking centrocytes. From a patient with 46,XX,t(2;12)(p12;p13). 
 
Comments 
According to the WHO classification of 
hematopoietic tumours, mantle cell lymphoma 
(MCL) is defined as a B-cell neoplasm composed of 
monomorphic small to medium-sized lymphoid cells 
with a CCND1 (cyclin D1) translocation. In recent 
years, it has been observed a small subset of 
lymphomas resembling conventional MCL both 
morphologically and phenotypically, with a similar 
gene expression profile but lacking the CCND1 
translocation (Fu et al, Blood, 2005).  
In 2013, Salaverria et al. investigated 40 well-
defined CCDN1-negative MCL and identified 22 
cases (55%) with CCND2 (cyclin D2) translocations 
(Salaverria et al, Blood, 2013). Interestingly, it was 
noted that CCND2 predominantly translocates to IG 
light chain genes (15/22, 68%) in contrast with 
CCND1 translocations.  
Finally, in CCND1-negative MCL, the identification 
of CCND2 gene rearrangement provides a very 
robust marker for diagnosis. 
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